Moreover, the high expression of CD200 on leukemia cells, through binding to CD200R, inhibits the cytotoxicity of NK cells, inducing immune evasion of leukemia cells, which is associated with the recurrence and progression of AML [116, 117]. Here, CD200R1 is linked to leukemia.